Anuva
Anuva is building the world's most diverse Genomic Bio/Data Bank, focusing on the Asian population to aid in drug discovery and disease research through extensive collaborations with public, private, and academic sectors.
Overview of Anuva
Anuva is developing the world's most diverse Genomic Bio/Data Bank to advance drug discovery by uncovering novel biological pathways. With comprehensive genomic data from over 4500 ethnicities within the Asian population, Anuva aims to create a resource for identifying genetic differences and their implications for disease and treatment.
Collaborations and Partnerships
Anuva works alongside public sector entities, private industry, and academic institutions to foster research and discovery. In particular, partnerships with BALCO Medical Centre and Max Healthcare facilitate the creation of Cancer Genomics Biobanks and genomic research on a variety of diseases in India. A strategic partnership with Helix followed the successful closure of a Series A funding round, further bolstering Anuva's research capabilities.
Genomic Bio/Data Bank Features
Anuva's Genomic Bio/Data Bank is designed with curated disease cohorts, deep phenotyping, and a biorepository to support expanded exploration. The bank empowers researchers by providing genomic data that reveals differences in disease susceptibility and treatment outcomes across diverse populations. It plays a pivotal role in identifying genetic variances between healthy individuals and those with diseases within a population.
Global Impact and Research Applications
While Anuva's research focuses on the Asian population, the implications and benefits are intended for a global audience. The insights from Anuva's Genomic Bio/Data Bank help drug discovery teams to make targeted treatments and understand their effects early on. Researchers leverage these data to generate knowledge that is otherwise unattainable with DNA sequence data alone.
Research Team and Expertise
Anuva's research team comprises experts from diverse specialties including molecular biology, population genetics, bioinformatics, clinical genetics/medicine, and genomics. Collaborating with pharmaceutical companies, biotech firms, hospitals, and academic institutions, the team accelerates the discovery process through shared expertise.